Clin2
NCT07527130Possibly a fitNot yet recruiting

Brain scan for inflammation in post-covid syndrome

COVID-19

Part of Infections, Lungs & breathing clinical trials.

This study uses a special PET scan to look for signs of inflammation in the brain that may be linked to long-lasting symptoms after COVID-19. The scan is a type of imaging that helps doctors see if there is ongoing inflammation, which could guide future treatments.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
10 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You must be a patient at Mayo Clinic
  • You must have had a confirmed COVID-19 infection
  • You must have been seen at the Post COVID Clinic or approved by the MAGPIES research group
  • You must be able to fully participate in the study and give your informed consent
  • If you are of childbearing potential, you must use reliable contraception during the study
  • You must not have implants that prevent PET scans, and you must not have claustrophobia

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06865222Recruiting
Magnetic brain stimulation for lingering COVID symptoms

This study tests whether a special type of magnetic stimulation (called TMS) can help with lingering symptoms after COVID-19, such as loss of smell, ringing in the ears, or fatigue. The treatment is safe and non-invasive, using a magnet placed near your head.

Rochester, Minnesota
NCT04786223Enrolling by invitation· Phase 2
Testing an anti-inflammatory PET imaging treatment in memory loss

This Phase 2 study tests whether targeting “neuroinflammation” (inflammation in the brain) can help in Alzheimer’s disease and related memory disorders. You may help researchers by doing several brain scans (including a special PET/CT scan) along with MRI and amyloid imaging to understand what’s happening in the brain.

Rochester, Minnesota
NCT05805839Enrolling by invitation· Phase 2
Study uses brain scans to understand demyelinating diseases

This trial compares scan results in people with multiple sclerosis or related demyelinating conditions versus people without inflammatory demyelinating diseases. The goal is to better understand what’s happening in the brain and how sex differences may play a role.

Rochester, Minnesota
NCT06920628Recruiting· Phase 1
Brain scan study for long COVID neurological symptoms

This study uses a special PET scan to look at brain inflammation in people with neurological symptoms after COVID-19. It aims to understand how inflammation might be linked to ongoing problems like brain fog or memory issues.

Bethesda, Maryland
NCT05656105Recruiting· Early Phase 1
PET scan study of brain inflammation after COVID

This early-phase study uses a special PET scan to look for signs of brain inflammation in people with ongoing (long-term) nervous system symptoms after COVID-19. It may help researchers understand what is driving symptoms and whether this imaging approach can detect inflammation.

Birmingham, Alabama
NCT07076862Recruiting· Early Phase 1
PET scan study for long COVID symptoms

This study uses a special PET scan to look at inflammation in the body of people with long COVID (symptoms lasting 3+ months after infection). The goal is to understand why symptoms persist and find better ways to help.

Sacramento, California

Hear when a new COVID-19 trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.